UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000034818
Receipt number R000039706
Scientific Title Analysis of the efficacy of brown rice-specific gamma-oryzanol for children with constipation
Date of disclosure of the study information 2018/11/08
Last modified on 2020/11/09 08:07:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Analysis of the efficacy of brown rice-specific gamma-oryzanol for children with constipation

Acronym

Analysis of the efficacy of brown rice-specific gamma-oryzanol for children with constipation

Scientific Title

Analysis of the efficacy of brown rice-specific gamma-oryzanol for children with constipation

Scientific Title:Acronym

Analysis of the efficacy of brown rice-specific gamma-oryzanol for children with constipation

Region

Japan


Condition

Condition

Constipation

Classification by specialty

Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the efficacy of gamma-oryzanol for children with constipation
Gamma-oryzanol is a brewed non-alcoholic beverage derived from brown rice

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Intestinal microbiota at 1 month from randomization (gamma-oryzanol group or control group)

Key secondary outcomes

Short chain fatty acids (Acetic acid, butyric acid, propionic acid, valeric acid) in serum
Symptoms of constipation


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Patient ingests brown rice-specific gamma-oryzanol for 1 month

Interventions/Control_2

Patient does not ingest brown rice-specific gamma-oryzanol for 1 month

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 years-old <=

Age-upper limit

18 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients who meet the criteria for chronic functional constipation disease

Key exclusion criteria

Decision of ineligibility by a physician

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Noriyuki
Middle name
Last name Yanagida

Organization

National Hospital Organization Sagamihara National Hospital

Division name

Department of Pediatrics

Zip code

252-0392

Address

18-1, Sakuradai, Minamiku, Sagamihara City, Kanagawa, Japan, 252-0392

TEL

042-742-8311

Email

sagamiharahospital@gmail.com


Public contact

Name of contact person

1st name Ken-ichi
Middle name
Last name Nagakura

Organization

National Hospital Organization Sagamihara National Hospital

Division name

Department of pediatrics

Zip code

252-0392

Address

18-1, Sakuradai, Minamiku, Sagamihara City, Kanagawa, Japan, 252-0392

TEL

042-742-8311

Homepage URL


Email

k.nagakura@foodallergy.jp


Sponsor or person

Institute

National Hospital Organization Sagamihara National Hospital

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development (AMED)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Hospital Organization Sagamihara National Hospital

Address

18-1, Sakuradai, Minamiku, Sagamihara City, Kanagawa, Japan, 252-0392

Tel

042-742-8311

Email

222-rinri@mail.hosp.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 11 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2018 Year 11 Month 01 Day

Date of IRB


Anticipated trial start date

2018 Year 11 Month 08 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 11 Month 08 Day

Last modified on

2020 Year 11 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000039706


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name